Knowledge Hub

Deep dives for pharma professionals

Research, innovation and market-trend explainers — the context behind the headlines, written for people who work in the industry.

69 articles in the hub
Market Trends

How Geopolitical Risks Are Reshaping API Supply Chains

API Supply Chains face tariffs, BIOSECURE and EU policy shifts. Here is how concentration, quality, and capacity risks play out, and how to map, score, and act.

Mrudula KulkarniOct 19, 2026
From Discovery to Preclinical Development: When Do Peptide Quality Requirements Need to Change?Market Trends

From Discovery to Preclinical Development: When Do Peptide Quality Requirements Need to Change?

Peptide Quality Requirements aren't fixed, they should scale with what the data needs to support, from discovery screening to GLP tox studies.

Pharma Now Editorial TeamOct 6, 2026
The Reproducibility Problem in Peptide Research Starts Earlier Than Most Teams ThinkMarket Trends

The Reproducibility Problem in Peptide Research Starts Earlier Than Most Teams Think

The Reproducibility Problem in Peptide Research is usually decided at procurement, not in the lab. Here's what teams miss before the first experiment.

Pharma Now Editorial TeamOct 6, 2026
Capital Investments In Next-Generation Facilities ExplainedMarket Trends

Capital Investments In Next-Generation Facilities Explained

Capital Investments In Next-Generation Facilities are turning pharma manufacturing into a top strategic priority, not a background function.

Simantini Singh DeoSep 18, 2026
Decentralized Manufacturing Models: Bringing Production Closer To The PatientMarket Trends

Decentralized Manufacturing Models: Bringing Production Closer To The Patient

Decentralized Manufacturing Models spread production across smaller local sites instead of one factory. Here's how they work and what's still holding them back.

Simantini Singh DeoSep 17, 2026
US Tariff Exposure By Manufacturing Footprint: A Sector MapMarket Trends

US Tariff Exposure By Manufacturing Footprint: A Sector Map

Learn how US pharmaceutical tariffs affect pharma manufacturers based on their manufacturing footprint, including India, APIs, generics, and onshoring.

Simantini Singh DeoAug 24, 2026
CDMO Trends 2026: What’s Driving Mergers And AcquisitionsMarket Trends

CDMO Trends 2026: What’s Driving Mergers And Acquisitions

CDMO trends 2026 show a structural consolidation wave — bigger deals, sharper specialization, and rising onshoring pressure reshaping manufacturing.

Simantini Singh DeoAug 18, 2026
Market Trends

Why Investment In Advanced Therapy Manufacturing Matters

Advanced therapy manufacturing is struggling to keep pace with cell and gene therapy breakthroughs, and the funding gap now decides patient access.

Simantini Singh DeoAug 18, 2026
Market Trends

Why GLP-1 Manufacturing Capacity Is Biggest Bottleneck in Pharma

A practical look at where GLP-1 manufacturing capacity stands today, and how Novo Nordisk, Lilly, and a growing CDMO network are closing the supply gap.

Vaibhavi M.Aug 12, 2026
CDMO Consolidation Trends 2026: Mergers & AcquisitionsMarket Trends

CDMO Consolidation Trends 2026: Mergers & Acquisitions

CDMO trends 2026 show a structural consolidation wave, bigger deals, sharper specialization, and rising onshoring pressure reshaping manufacturing.

Simantini Singh DeoAug 7, 2026
Beyond the Pharmacy Counter: How Indian Pharmacy Graduates Are Transforming U.S. Healthcare Through Virtual Clinical SupportMarket Trends

Beyond the Pharmacy Counter: How Indian Pharmacy Graduates Are Transforming U.S. Healthcare Through Virtual Clinical Support

One antibiotic course, two delayed symptoms, how silent gut disruption connects acne and vaginal infections months later.

Dr. Sainath Chary GannojiJul 28, 2026
Top 11 Pharma Companies In Dubai You Must Know AboutMarket Trends

Top 11 Pharma Companies In Dubai You Must Know About

A curated list of Dubai's home-grown pharma manufacturers and distributors, real companies built, run, and headquartered in the emirate.

Simantini Singh DeoJul 15, 2026